Émilie Routier
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 25
- CAR-T cell therapy research 14
- Cutaneous Melanoma Detection and Management 10
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 3
- Immunology top 2%
- Immunotherapy and Immune Responses 10
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 19
- Dermatology top 2%
- Biological Psychiatry top 10%
-
- Nonmelanoma Skin Cancer Studies 7
- Co-authors
- Caroline RobertChristine MateusÉmilie LanoyAlexander M.M. EggermontFranck CarbonnelJean‐Charles SoriaStéphane ChampiatC. Boutros
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Émilie Routier
51 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 2.7k
- Immunology 998
- Molecular Biology 1.5k
- Dermatology 178
- Biological Psychiatry 49
Countries citing papers authored by Émilie Routier
This map shows the geographic impact of Émilie Routier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Émilie Routier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Émilie Routier more than expected).
Fields of papers citing papers by Émilie Routier
This network shows the impact of papers produced by Émilie Routier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Émilie Routier. The network helps show where Émilie Routier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Émilie Routier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 0 | |
| 8 | 2018 | 10 | |
| 9 | 2017 | 12 | |
| 10 | 2016 | 33 | |
| 11 | 2016 | 1 | |
| 12 | 2016 | 14 | |
| 13 | 2016 | 2 | |
| 14 | 2015 | 23 | |
| 15 | 2014 | 7 | |
| 16 | 2014 | 5 | |
| 17 | 2013 | 247 | |
| 18 | 2013 | 71 | |
| 19 | 2012 | 122 | |
| 20 | 2010 | 1 |
About Émilie Routier
Émilie Routier is a scholar working on Oncology, Dermatology and Immunology, having authored 56 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Melanoma and MAPK Pathways (19 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (10 papers), Cutaneous Melanoma Detection and Management (10 papers), Nonmelanoma Skin Cancer Studies (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (2.7k citations), Immunology (998 citations) and Molecular Biology (1.5k citations). Émilie Routier has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Caroline Robert, Christine Mateus, Émilie Lanoy, Alexander M.M. Eggermont, Franck Carbonnel, Jean‐Charles Soria, Stéphane Champiat, C. Boutros, Nathalie Chaput and Matthieu Texier. Their work appears in journals such as Nature, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.